InvestorsHub Logo
Followers 28
Posts 2743
Boards Moderated 0
Alias Born 01/11/2019

Re: None

Thursday, 03/18/2021 8:57:59 AM

Thursday, March 18, 2021 8:57:59 AM

Post# of 73539
$VDRM Way undervalued Biopharma

-PINK Current
-Debt free
-850M float
-Revenue producing company
-Licensing agreements hospitals in 6 states
-FDA approved products
-Patent Pending Technologies
-Expansion into all 50 states
-500,000 units to be sold in 2021

-The FDA approved the registration of a new 55 ml Vitastem spray bottle. This came at the request of hospitals that have tested the product. A larger spray version will be easier to apply the medication to large wounds.
-Liberdol, a new relief pain product was officially launched in 2020. The analgesics market in the U.S. is estimated to be more than $12 billion dollars.
-An extended line of credit was secured for financing future manufacturing. We anticipate sales to top 500,000 units in 2021.
-A large national hospital chain and a major health insurance company have completed successful testing of the Vitastem product. We are now in the final stages of discussions to determine the size of the initial purchase.

https://www.globenewswire.com/news-release/2021/01/13/2157661/0/en/ViaDerma-Inc-Provides-Review-of-2020-and-Looks-Forward-to-2021.html

500,000 UNITS TO BE SOLD !